US EditionPublished • loading... • Updated
Trump Set to Announce Blockbuster Deals with Big Pharma to Slash Drug Prices
The initiative aims to stop Americans from subsidizing lower drug prices abroad and involves at least five pharmaceutical companies, officials said.
- On Dec. 19, President Donald Trump announced deals with nine pharmaceutical companies to cut some U.S. drug prices in exchange for three-year tariff reprieves, with 14 of 17 targeted drugmakers agreeing to lower Medicaid prices and offer discounted drugs.
- Motivated by U.S. price disparities, the administration pursues the Most Favored Nation initiative, echoing earlier deals by Pfizer Inc. and AstraZeneca to align United States drug prices.
- Several companies committed to donations and emergency manufacturing, and Merck & Co., Bristol-Myers Squibb Co. and GSK agreed to donate six months’ raw materials to a national stockpile of active pharmaceutical ingredients.
- A White House briefing is set for Friday at 1 p.m. in the Roosevelt Room with at least five drugmakers, while Deputy Attorney General Todd Blanche said the DOJ will send Congress "several hundred thousand" documents Friday.
- Democrats have demanded more details from companies about confidential tariff-relief deals while the Department of Justice met its deadline to release Jeffrey Epstein files with victim protections.
Insights by Ground AI
12 Articles
12 Articles
Trump LIVE | US President announces deals to lower prices of drugs and pharmaceuticals
US President Donald Trump delivers a LIVE address announcing new deals aimed at lowering prescription drug and pharmaceutical prices. The move targets rising healthcare costs and takes on Big Pharma as Americans face mounting expenses.
·India
Read Full Article
In Video: LIVE: Trump makes an announcement on lowering drug prices
The Trump Administration Announces Historic Agreement to Bring Down Drug Prices In a major address, President Trump announced a groundbreaking agreement with top pharmaceutical companies to reduce drug prices in the United States. The companies, including Johnson & Johnson, Sanofi, and others, have agreed to sell their drugs at heavily discounted prices, making them more affordable for Americans. The Golden Card The President highlighted a new p…
Coverage Details
Total News Sources12
Leaning Left0Leaning Right7Center3Last UpdatedBias Distribution70% Right
Bias Distribution
- 70% of the sources lean Right
70% Right
C 30%
R 70%
Factuality
To view factuality data please Upgrade to Premium
